Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Schizophrenia | 129 | 2013 | 6915 | 5.840 |
Why?
|
Delusions | 16 | 2013 | 298 | 3.800 |
Why?
|
Vitamin D Deficiency | 47 | 2014 | 1379 | 3.420 |
Why?
|
Paternal Age | 13 | 2014 | 87 | 2.790 |
Why?
|
Psychotic Disorders | 44 | 2014 | 3193 | 2.690 |
Why?
|
Dyskinesia, Drug-Induced | 16 | 2011 | 165 | 2.200 |
Why?
|
Vitamin D | 24 | 2013 | 3291 | 2.110 |
Why?
|
Seasons | 25 | 2013 | 1522 | 1.790 |
Why?
|
Schizophrenic Psychology | 20 | 2011 | 1646 | 1.660 |
Why?
|
Australia | 41 | 2014 | 1289 | 1.600 |
Why?
|
Receptors, Calcitriol | 9 | 2013 | 359 | 1.090 |
Why?
|
Mental Disorders | 18 | 2014 | 6796 | 1.060 |
Why?
|
Maternal Age | 5 | 2014 | 807 | 1.000 |
Why?
|
Prenatal Exposure Delayed Effects | 24 | 2012 | 2496 | 0.980 |
Why?
|
Antipsychotic Agents | 25 | 2012 | 3061 | 0.890 |
Why?
|
Brain | 31 | 2012 | 26951 | 0.840 |
Why?
|
Calcifediol | 7 | 2012 | 161 | 0.840 |
Why?
|
Affective Disorders, Psychotic | 4 | 2009 | 186 | 0.750 |
Why?
|
Schizophrenia, Paranoid | 2 | 2013 | 102 | 0.750 |
Why?
|
Health Surveys | 16 | 2014 | 4063 | 0.690 |
Why?
|
Marijuana Abuse | 5 | 2013 | 411 | 0.670 |
Why?
|
Cholecalciferol | 7 | 2013 | 550 | 0.640 |
Why?
|
Research | 4 | 2013 | 1974 | 0.640 |
Why?
|
Risk Factors | 66 | 2014 | 74359 | 0.620 |
Why?
|
Anthropometry | 4 | 2007 | 1348 | 0.620 |
Why?
|
Patellar Ligament | 3 | 2010 | 64 | 0.620 |
Why?
|
Psychiatric Status Rating Scales | 21 | 2013 | 6015 | 0.600 |
Why?
|
Dietary Supplements | 5 | 2013 | 3392 | 0.600 |
Why?
|
Psychoses, Substance-Induced | 2 | 2010 | 99 | 0.600 |
Why?
|
Employment | 3 | 2014 | 1112 | 0.590 |
Why?
|
Birth Weight | 4 | 2007 | 2097 | 0.590 |
Why?
|
Olfactory Mucosa | 10 | 2013 | 99 | 0.580 |
Why?
|
Behavior, Animal | 17 | 2013 | 1866 | 0.580 |
Why?
|
Queensland | 11 | 2010 | 53 | 0.580 |
Why?
|
Female | 186 | 2014 | 391270 | 0.570 |
Why?
|
Developmental Disabilities | 6 | 2013 | 1504 | 0.570 |
Why?
|
Male | 175 | 2014 | 359744 | 0.560 |
Why?
|
Humans | 245 | 2014 | 760621 | 0.540 |
Why?
|
Child of Impaired Parents | 2 | 2012 | 459 | 0.540 |
Why?
|
Vitamin E | 3 | 2011 | 872 | 0.530 |
Why?
|
Hallucinations | 5 | 2010 | 366 | 0.530 |
Why?
|
Cognition | 6 | 2013 | 6957 | 0.530 |
Why?
|
Denmark | 9 | 2014 | 760 | 0.520 |
Why?
|
Mentally Ill Persons | 3 | 2014 | 127 | 0.520 |
Why?
|
Neurons | 17 | 2011 | 9426 | 0.510 |
Why?
|
Emigrants and Immigrants | 3 | 2011 | 539 | 0.510 |
Why?
|
Sex Factors | 30 | 2014 | 10547 | 0.500 |
Why?
|
Adolescent | 70 | 2014 | 87810 | 0.500 |
Why?
|
Prevalence | 29 | 2013 | 15687 | 0.500 |
Why?
|
Cryopreservation | 4 | 2006 | 717 | 0.500 |
Why?
|
Adult | 120 | 2014 | 219994 | 0.480 |
Why?
|
Environment | 3 | 2010 | 1118 | 0.470 |
Why?
|
Dermatoglyphics | 3 | 2003 | 20 | 0.470 |
Why?
|
Cognition Disorders | 7 | 2012 | 3976 | 0.470 |
Why?
|
Pregnancy | 48 | 2013 | 29749 | 0.470 |
Why?
|
Registries | 10 | 2014 | 8469 | 0.460 |
Why?
|
Demography | 4 | 2008 | 1650 | 0.460 |
Why?
|
Sex Distribution | 10 | 2013 | 2295 | 0.450 |
Why?
|
Competitive Behavior | 1 | 2014 | 77 | 0.440 |
Why?
|
Infant, Newborn | 22 | 2012 | 26181 | 0.440 |
Why?
|
Rickets | 2 | 2012 | 71 | 0.430 |
Why?
|
25-Hydroxyvitamin D 2 | 2 | 2012 | 40 | 0.430 |
Why?
|
Body Height | 3 | 2009 | 1570 | 0.430 |
Why?
|
Family | 5 | 2013 | 3189 | 0.430 |
Why?
|
Cytoskeleton | 3 | 2006 | 1167 | 0.420 |
Why?
|
Birth Rate | 4 | 2003 | 168 | 0.420 |
Why?
|
Salts | 1 | 2012 | 64 | 0.420 |
Why?
|
Anions | 1 | 2012 | 137 | 0.410 |
Why?
|
Urban Population | 6 | 2010 | 2022 | 0.410 |
Why?
|
Cross-Cultural Comparison | 7 | 2012 | 633 | 0.410 |
Why?
|
Fetal Development | 4 | 2011 | 766 | 0.410 |
Why?
|
Motor Activity | 14 | 2013 | 2687 | 0.400 |
Why?
|
Cell Cycle | 6 | 2011 | 2934 | 0.400 |
Why?
|
Nerve Tissue Proteins | 7 | 2011 | 4407 | 0.390 |
Why?
|
Cannabis | 3 | 2013 | 436 | 0.380 |
Why?
|
Incidence | 22 | 2014 | 21392 | 0.380 |
Why?
|
Neurotransmitter Agents | 3 | 2011 | 663 | 0.370 |
Why?
|
Focal Adhesions | 2 | 2013 | 114 | 0.370 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2014 | 370 | 0.370 |
Why?
|
Age Factors | 28 | 2014 | 18416 | 0.360 |
Why?
|
Osteoblasts | 2 | 2006 | 1142 | 0.360 |
Why?
|
Young Adult | 37 | 2014 | 58741 | 0.360 |
Why?
|
Educational Status | 3 | 2013 | 2515 | 0.360 |
Why?
|
Epidemiologic Studies | 4 | 2008 | 670 | 0.360 |
Why?
|
Developmental Biology | 1 | 2011 | 80 | 0.360 |
Why?
|
Object Attachment | 1 | 2013 | 324 | 0.350 |
Why?
|
Middle Aged | 89 | 2014 | 220352 | 0.350 |
Why?
|
Growth | 1 | 2012 | 365 | 0.350 |
Why?
|
Islam | 1 | 2011 | 71 | 0.350 |
Why?
|
Topography, Medical | 2 | 2006 | 37 | 0.340 |
Why?
|
Brain Chemistry | 2 | 2005 | 959 | 0.340 |
Why?
|
Violence | 2 | 2007 | 927 | 0.330 |
Why?
|
25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 2 | 2010 | 58 | 0.330 |
Why?
|
Alcohol-Related Disorders | 1 | 2011 | 235 | 0.330 |
Why?
|
Neuropsychiatry | 1 | 2010 | 76 | 0.330 |
Why?
|
Vitamin D-Binding Protein | 1 | 2010 | 131 | 0.320 |
Why?
|
Substance-Related Disorders | 8 | 2013 | 4371 | 0.310 |
Why?
|
Exploratory Behavior | 8 | 2014 | 273 | 0.310 |
Why?
|
Speech Disorders | 1 | 2009 | 180 | 0.310 |
Why?
|
Dopamine | 7 | 2011 | 1595 | 0.310 |
Why?
|
Rats | 33 | 2014 | 23711 | 0.300 |
Why?
|
Social Adjustment | 2 | 2008 | 632 | 0.300 |
Why?
|
Age Distribution | 7 | 2013 | 2893 | 0.300 |
Why?
|
Health | 1 | 2011 | 396 | 0.300 |
Why?
|
Mothers | 2 | 2012 | 2186 | 0.300 |
Why?
|
Affective Symptoms | 2 | 2008 | 416 | 0.300 |
Why?
|
Hospitals, Psychiatric | 4 | 2005 | 320 | 0.290 |
Why?
|
Rats, Sprague-Dawley | 22 | 2014 | 8158 | 0.290 |
Why?
|
Life Change Events | 2 | 2010 | 952 | 0.290 |
Why?
|
Animals | 65 | 2014 | 167963 | 0.280 |
Why?
|
Cohort Studies | 24 | 2014 | 41335 | 0.280 |
Why?
|
Blood Chemical Analysis | 1 | 2009 | 437 | 0.280 |
Why?
|
Calcium Channel Blockers | 2 | 2001 | 694 | 0.280 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 6 | 2011 | 1988 | 0.280 |
Why?
|
Causality | 6 | 2010 | 1242 | 0.280 |
Why?
|
Schizotypal Personality Disorder | 1 | 2008 | 290 | 0.280 |
Why?
|
Cholinergic Agents | 3 | 2004 | 96 | 0.280 |
Why?
|
Calcium Signaling | 1 | 2011 | 732 | 0.270 |
Why?
|
Face | 2 | 2003 | 1017 | 0.270 |
Why?
|
Nucleus Accumbens | 2 | 2009 | 365 | 0.270 |
Why?
|
Hot Temperature | 3 | 2010 | 1435 | 0.270 |
Why?
|
Bipolar Disorder | 9 | 2011 | 5078 | 0.270 |
Why?
|
Neuropsychological Tests | 9 | 2010 | 7021 | 0.260 |
Why?
|
Vitamins | 2 | 2013 | 1634 | 0.260 |
Why?
|
Accidents | 1 | 2007 | 166 | 0.260 |
Why?
|
Memory Disorders | 2 | 2005 | 1197 | 0.260 |
Why?
|
Siblings | 1 | 2010 | 824 | 0.260 |
Why?
|
Parturition | 3 | 2012 | 446 | 0.260 |
Why?
|
Interview, Psychological | 4 | 2012 | 810 | 0.260 |
Why?
|
Dizocilpine Maleate | 6 | 2013 | 172 | 0.260 |
Why?
|
Parents | 3 | 2012 | 3549 | 0.250 |
Why?
|
Aged | 49 | 2013 | 169152 | 0.250 |
Why?
|
Cross-Sectional Studies | 17 | 2013 | 25942 | 0.250 |
Why?
|
Longitudinal Studies | 10 | 2013 | 14495 | 0.250 |
Why?
|
Mythology | 1 | 2005 | 15 | 0.250 |
Why?
|
Gap Junctions | 1 | 2006 | 230 | 0.250 |
Why?
|
Fellowships and Scholarships | 1 | 2014 | 1116 | 0.250 |
Why?
|
Child | 32 | 2014 | 79806 | 0.240 |
Why?
|
Disease Outbreaks | 2 | 2010 | 1758 | 0.240 |
Why?
|
Patient Admission | 4 | 2000 | 1386 | 0.240 |
Why?
|
Parent-Child Relations | 1 | 2009 | 758 | 0.240 |
Why?
|
Parkinson Disease | 4 | 2013 | 2859 | 0.240 |
Why?
|
Geography | 3 | 2010 | 661 | 0.240 |
Why?
|
Calcium | 4 | 2012 | 5725 | 0.230 |
Why?
|
Gene Expression Regulation, Developmental | 4 | 2011 | 3604 | 0.230 |
Why?
|
Malnutrition | 1 | 2010 | 640 | 0.230 |
Why?
|
Disease Models, Animal | 21 | 2014 | 18137 | 0.230 |
Why?
|
Child Behavior | 1 | 2009 | 847 | 0.220 |
Why?
|
Models, Animal | 1 | 2010 | 2117 | 0.220 |
Why?
|
Child Behavior Disorders | 1 | 2008 | 805 | 0.220 |
Why?
|
Fetal Blood | 1 | 2010 | 1343 | 0.220 |
Why?
|
Lithium Carbonate | 1 | 2004 | 179 | 0.220 |
Why?
|
Hyperthermia, Induced | 2 | 2005 | 417 | 0.220 |
Why?
|
Emigration and Immigration | 2 | 2005 | 395 | 0.210 |
Why?
|
Child, Preschool | 21 | 2014 | 42063 | 0.210 |
Why?
|
Hyperkinesis | 3 | 2007 | 89 | 0.210 |
Why?
|
Neuronal Plasticity | 1 | 2011 | 1430 | 0.210 |
Why?
|
DNA Copy Number Variations | 1 | 2011 | 2013 | 0.210 |
Why?
|
Community Mental Health Services | 3 | 2013 | 392 | 0.210 |
Why?
|
Gait Disorders, Neurologic | 1 | 2004 | 238 | 0.200 |
Why?
|
Social Support | 1 | 2012 | 2145 | 0.200 |
Why?
|
Anxiety Disorders | 2 | 2013 | 2714 | 0.200 |
Why?
|
Climate | 1 | 2003 | 147 | 0.200 |
Why?
|
Polymorphism, Single Nucleotide | 6 | 2011 | 15789 | 0.200 |
Why?
|
Chromatography, Gas | 1 | 2001 | 151 | 0.200 |
Why?
|
Smoking | 3 | 2012 | 9073 | 0.200 |
Why?
|
Bone and Bones | 1 | 2012 | 2560 | 0.200 |
Why?
|
Corpus Striatum | 2 | 2013 | 1233 | 0.200 |
Why?
|
Cryoprotective Agents | 2 | 2006 | 128 | 0.200 |
Why?
|
Aged, 80 and over | 19 | 2014 | 58995 | 0.200 |
Why?
|
Genetic Variation | 3 | 2011 | 6551 | 0.200 |
Why?
|
Models, Biological | 9 | 2013 | 9467 | 0.190 |
Why?
|
Synapses | 1 | 2011 | 1757 | 0.190 |
Why?
|
Social Class | 4 | 2006 | 2005 | 0.190 |
Why?
|
Actins | 2 | 2006 | 2049 | 0.190 |
Why?
|
Comorbidity | 10 | 2013 | 10551 | 0.190 |
Why?
|
Poliomyelitis | 1 | 2002 | 94 | 0.190 |
Why?
|
Sunlight | 2 | 2007 | 337 | 0.190 |
Why?
|
Cardiography, Impedance | 1 | 2001 | 40 | 0.190 |
Why?
|
Vocabulary | 1 | 2002 | 165 | 0.190 |
Why?
|
Suicidal Ideation | 1 | 2011 | 1425 | 0.190 |
Why?
|
Olfaction Disorders | 1 | 2004 | 224 | 0.190 |
Why?
|
Mesencephalon | 3 | 2013 | 332 | 0.190 |
Why?
|
Culture | 1 | 2005 | 622 | 0.180 |
Why?
|
Learning | 2 | 2007 | 1739 | 0.180 |
Why?
|
Odds Ratio | 7 | 2014 | 9716 | 0.180 |
Why?
|
Pregnancy Complications | 6 | 2013 | 2942 | 0.180 |
Why?
|
Locomotion | 2 | 2014 | 387 | 0.180 |
Why?
|
Crime Victims | 1 | 2004 | 328 | 0.180 |
Why?
|
Mood Disorders | 2 | 2003 | 1124 | 0.180 |
Why?
|
Maternal Exposure | 1 | 2007 | 1045 | 0.180 |
Why?
|
Social Environment | 3 | 2010 | 1022 | 0.180 |
Why?
|
Family Health | 3 | 2011 | 1257 | 0.180 |
Why?
|
Nerve Growth Factors | 3 | 2003 | 562 | 0.180 |
Why?
|
Stress, Psychological | 4 | 2011 | 4446 | 0.180 |
Why?
|
Case-Control Studies | 15 | 2013 | 22053 | 0.170 |
Why?
|
Optics and Photonics | 1 | 2001 | 305 | 0.170 |
Why?
|
Mental Health Services | 6 | 2012 | 1717 | 0.170 |
Why?
|
Poverty | 1 | 2011 | 2695 | 0.170 |
Why?
|
GABA Modulators | 1 | 2000 | 109 | 0.170 |
Why?
|
Emotions | 1 | 2011 | 2734 | 0.170 |
Why?
|
Alcohol Drinking | 2 | 2011 | 4013 | 0.170 |
Why?
|
Craniofacial Abnormalities | 1 | 2002 | 315 | 0.170 |
Why?
|
Quality-Adjusted Life Years | 4 | 2012 | 1724 | 0.160 |
Why?
|
Periodicity | 3 | 2007 | 348 | 0.160 |
Why?
|
Acoustic Stimulation | 5 | 2014 | 1232 | 0.160 |
Why?
|
Vulnerable Populations | 1 | 2004 | 696 | 0.160 |
Why?
|
Cholinergic Antagonists | 1 | 2000 | 164 | 0.160 |
Why?
|
Population Groups | 2 | 2010 | 211 | 0.160 |
Why?
|
Nasal Mucosa | 1 | 2002 | 412 | 0.160 |
Why?
|
Parkinsonian Disorders | 1 | 2002 | 284 | 0.160 |
Why?
|
Child Care | 1 | 1999 | 121 | 0.160 |
Why?
|
Autistic Disorder | 3 | 2013 | 1216 | 0.160 |
Why?
|
Marital Status | 2 | 2012 | 433 | 0.150 |
Why?
|
Health Status | 4 | 2012 | 4081 | 0.150 |
Why?
|
Anti-Anxiety Agents | 2 | 2002 | 397 | 0.150 |
Why?
|
Abnormalities, Multiple | 2 | 2003 | 1415 | 0.150 |
Why?
|
Amphetamine | 4 | 2013 | 224 | 0.150 |
Why?
|
Wounds and Injuries | 5 | 2012 | 2477 | 0.150 |
Why?
|
Oligonucleotide Array Sequence Analysis | 8 | 2011 | 3775 | 0.140 |
Why?
|
Genetic Predisposition to Disease | 10 | 2013 | 17790 | 0.140 |
Why?
|
Reaction Time | 7 | 2013 | 2075 | 0.140 |
Why?
|
Infant | 15 | 2013 | 36060 | 0.140 |
Why?
|
Statistics as Topic | 3 | 2008 | 2362 | 0.140 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2009 | 3701 | 0.140 |
Why?
|
Mass Screening | 3 | 2010 | 5423 | 0.140 |
Why?
|
Analysis of Variance | 9 | 2012 | 6238 | 0.140 |
Why?
|
Dependovirus | 1 | 2002 | 709 | 0.140 |
Why?
|
Excitatory Amino Acid Antagonists | 2 | 2011 | 448 | 0.140 |
Why?
|
Thinking | 1 | 2000 | 319 | 0.140 |
Why?
|
Follow-Up Studies | 12 | 2014 | 39261 | 0.140 |
Why?
|
Animals, Newborn | 8 | 2012 | 2672 | 0.140 |
Why?
|
Substantia Nigra | 2 | 2013 | 350 | 0.140 |
Why?
|
Dose-Response Relationship, Drug | 10 | 2012 | 10827 | 0.140 |
Why?
|
Steroids | 1 | 2001 | 928 | 0.130 |
Why?
|
Community Health Planning | 3 | 2011 | 166 | 0.130 |
Why?
|
Finland | 3 | 2008 | 603 | 0.130 |
Why?
|
Head | 1 | 2002 | 922 | 0.130 |
Why?
|
Temperature | 4 | 2010 | 2221 | 0.130 |
Why?
|
Age of Onset | 4 | 2012 | 3301 | 0.130 |
Why?
|
Affect | 1 | 2004 | 1480 | 0.130 |
Why?
|
Mental Health | 2 | 2011 | 3213 | 0.130 |
Why?
|
Chromatography, Liquid | 2 | 2010 | 987 | 0.130 |
Why?
|
Benzodiazepines | 3 | 2003 | 1131 | 0.130 |
Why?
|
Chi-Square Distribution | 2 | 2013 | 3465 | 0.130 |
Why?
|
Fetal Nutrition Disorders | 2 | 2005 | 8 | 0.130 |
Why?
|
Awareness | 1 | 2000 | 646 | 0.130 |
Why?
|
Polymorphism, Genetic | 1 | 2006 | 4291 | 0.130 |
Why?
|
Genome-Wide Association Study | 3 | 2013 | 12626 | 0.130 |
Why?
|
Early Diagnosis | 2 | 2012 | 1180 | 0.130 |
Why?
|
Heat-Shock Response | 1 | 1996 | 179 | 0.130 |
Why?
|
Brazil | 3 | 2007 | 1218 | 0.120 |
Why?
|
Depressive Disorder, Major | 2 | 2010 | 4744 | 0.120 |
Why?
|
Risk | 5 | 2014 | 9631 | 0.120 |
Why?
|
Academic Medical Centers | 1 | 2005 | 2754 | 0.120 |
Why?
|
Psychometrics | 3 | 2009 | 3051 | 0.120 |
Why?
|
Sensory Gating | 1 | 2014 | 47 | 0.120 |
Why?
|
Fertility | 1 | 1999 | 773 | 0.120 |
Why?
|
Meta-Analysis as Topic | 4 | 2012 | 1376 | 0.110 |
Why?
|
Swimming | 2 | 2005 | 207 | 0.110 |
Why?
|
Neoplasms | 3 | 2013 | 22072 | 0.110 |
Why?
|
Developed Countries | 2 | 2007 | 442 | 0.110 |
Why?
|
Cell Line | 9 | 2011 | 15620 | 0.110 |
Why?
|
Haloperidol | 5 | 2006 | 389 | 0.110 |
Why?
|
Transients and Migrants | 2 | 2008 | 162 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 9 | 2011 | 10344 | 0.110 |
Why?
|
Confidence Intervals | 2 | 2014 | 2932 | 0.110 |
Why?
|
Influenza, Human | 2 | 1995 | 1528 | 0.110 |
Why?
|
Molecular Biology | 2 | 2005 | 580 | 0.110 |
Why?
|
Tandem Mass Spectrometry | 2 | 2010 | 1189 | 0.110 |
Why?
|
Phenotype | 11 | 2012 | 16546 | 0.110 |
Why?
|
Magnesium Chloride | 1 | 2012 | 30 | 0.110 |
Why?
|
Calibration | 2 | 2009 | 816 | 0.110 |
Why?
|
Nonlinear Dynamics | 2 | 2007 | 494 | 0.110 |
Why?
|
Hemidesmosomes | 1 | 2012 | 5 | 0.110 |
Why?
|
Disability Evaluation | 2 | 2012 | 1826 | 0.110 |
Why?
|
Mice | 17 | 2012 | 81208 | 0.110 |
Why?
|
Vocational Education | 1 | 2012 | 6 | 0.110 |
Why?
|
Absorption | 1 | 2012 | 243 | 0.100 |
Why?
|
SOXF Transcription Factors | 1 | 2012 | 31 | 0.100 |
Why?
|
Epidermolysis Bullosa | 1 | 2012 | 29 | 0.100 |
Why?
|
Neural Inhibition | 3 | 2006 | 589 | 0.100 |
Why?
|
Rabbits | 3 | 2010 | 4773 | 0.100 |
Why?
|
Intelligence Tests | 1 | 2013 | 500 | 0.100 |
Why?
|
International Classification of Diseases | 4 | 2012 | 894 | 0.100 |
Why?
|
DNA | 1 | 2006 | 7233 | 0.100 |
Why?
|
Carbon Monoxide Poisoning | 2 | 1989 | 66 | 0.100 |
Why?
|
Association | 1 | 2012 | 52 | 0.100 |
Why?
|
Risk Assessment | 6 | 2014 | 24123 | 0.100 |
Why?
|
Interpersonal Relations | 2 | 2013 | 1428 | 0.100 |
Why?
|
Biological Availability | 1 | 2012 | 395 | 0.100 |
Why?
|
Time Factors | 13 | 2013 | 40165 | 0.100 |
Why?
|
Breeding | 1 | 2011 | 51 | 0.100 |
Why?
|
Language Tests | 2 | 2009 | 190 | 0.100 |
Why?
|
History, 20th Century | 2 | 2013 | 2773 | 0.100 |
Why?
|
Sensitivity and Specificity | 5 | 2012 | 14660 | 0.090 |
Why?
|
Memory | 3 | 2009 | 2179 | 0.090 |
Why?
|
Carbamates | 1 | 2012 | 192 | 0.090 |
Why?
|
Urine | 1 | 2012 | 363 | 0.090 |
Why?
|
Influenza A virus | 1 | 1994 | 457 | 0.090 |
Why?
|
Mortality | 3 | 2012 | 2916 | 0.090 |
Why?
|
Psychological Tests | 1 | 2013 | 639 | 0.090 |
Why?
|
Congenital Abnormalities | 1 | 1995 | 704 | 0.090 |
Why?
|
Glutaral | 1 | 2010 | 76 | 0.090 |
Why?
|
Acidosis | 1 | 2012 | 268 | 0.090 |
Why?
|
Prefrontal Cortex | 3 | 2013 | 2212 | 0.090 |
Why?
|
Models, Genetic | 2 | 2011 | 3442 | 0.090 |
Why?
|
Psychotherapy | 1 | 1999 | 1640 | 0.090 |
Why?
|
Epigenesis, Genetic | 1 | 2004 | 3758 | 0.090 |
Why?
|
Spermatozoa | 2 | 2013 | 631 | 0.090 |
Why?
|
Sound Localization | 1 | 2010 | 60 | 0.090 |
Why?
|
History, 19th Century | 1 | 2013 | 720 | 0.090 |
Why?
|
Cost of Illness | 2 | 2010 | 1940 | 0.090 |
Why?
|
Starvation | 1 | 2010 | 140 | 0.090 |
Why?
|
Sweden | 3 | 2013 | 1381 | 0.090 |
Why?
|
GABA Agonists | 2 | 2001 | 105 | 0.090 |
Why?
|
Data Collection | 3 | 2007 | 3315 | 0.090 |
Why?
|
Genotype | 6 | 2010 | 12960 | 0.090 |
Why?
|
Folic Acid Deficiency | 1 | 2010 | 117 | 0.090 |
Why?
|
Forecasting | 3 | 2007 | 2932 | 0.090 |
Why?
|
Heating | 1 | 2010 | 101 | 0.090 |
Why?
|
Severity of Illness Index | 5 | 2011 | 15840 | 0.090 |
Why?
|
Psychotropic Drugs | 2 | 2013 | 883 | 0.090 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2013 | 389 | 0.090 |
Why?
|
Mouth Mucosa | 1 | 2012 | 426 | 0.080 |
Why?
|
Solutions | 1 | 2010 | 419 | 0.080 |
Why?
|
Cause of Death | 2 | 2012 | 3725 | 0.080 |
Why?
|
Acrocallosal Syndrome | 1 | 2009 | 1 | 0.080 |
Why?
|
Puberty | 2 | 2013 | 498 | 0.080 |
Why?
|
Ultrasonics | 1 | 2010 | 207 | 0.080 |
Why?
|
Radioimmunoassay | 1 | 2010 | 866 | 0.080 |
Why?
|
Aging | 5 | 2012 | 8651 | 0.080 |
Why?
|
Gene Expression Profiling | 4 | 2011 | 9411 | 0.080 |
Why?
|
Residence Characteristics | 2 | 2010 | 2062 | 0.080 |
Why?
|
Signal Transduction | 10 | 2013 | 23376 | 0.080 |
Why?
|
Chromatography, High Pressure Liquid | 3 | 2010 | 1544 | 0.080 |
Why?
|
Fibroblasts | 3 | 2011 | 4090 | 0.080 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2007 | 4555 | 0.080 |
Why?
|
Symbiosis | 1 | 2011 | 291 | 0.080 |
Why?
|
Space Perception | 2 | 2003 | 464 | 0.080 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2010 | 263 | 0.080 |
Why?
|
Maze Learning | 3 | 2005 | 477 | 0.080 |
Why?
|
Preservation, Biological | 1 | 1988 | 26 | 0.080 |
Why?
|
Skin Pigmentation | 1 | 2011 | 277 | 0.080 |
Why?
|
Attention | 4 | 2012 | 2387 | 0.080 |
Why?
|
Jews | 1 | 2010 | 364 | 0.080 |
Why?
|
Nervous System Diseases | 2 | 2011 | 1647 | 0.080 |
Why?
|
Socioeconomic Factors | 4 | 2012 | 7806 | 0.080 |
Why?
|
Neural Stem Cells | 2 | 2013 | 884 | 0.080 |
Why?
|
Marijuana Smoking | 1 | 2011 | 257 | 0.080 |
Why?
|
Prospective Studies | 8 | 2012 | 54303 | 0.080 |
Why?
|
Neurosciences | 1 | 2013 | 353 | 0.080 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2008 | 283 | 0.080 |
Why?
|
Nerve Growth Factor | 3 | 2005 | 158 | 0.080 |
Why?
|
Immunity, Mucosal | 1 | 2011 | 482 | 0.080 |
Why?
|
Restraint, Physical | 2 | 2006 | 186 | 0.080 |
Why?
|
Respiratory Mucosa | 1 | 2011 | 441 | 0.080 |
Why?
|
Nervous System Malformations | 2 | 2003 | 244 | 0.070 |
Why?
|
Health Services Needs and Demand | 2 | 2014 | 1399 | 0.070 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2012 | 2502 | 0.070 |
Why?
|
Lipid Metabolism | 1 | 1996 | 1902 | 0.070 |
Why?
|
Cytoplasm | 1 | 2012 | 1516 | 0.070 |
Why?
|
Cell Membrane | 1 | 1997 | 3682 | 0.070 |
Why?
|
Ovum | 1 | 1988 | 187 | 0.070 |
Why?
|
Poisoning | 1 | 1989 | 252 | 0.070 |
Why?
|
Random Allocation | 3 | 2012 | 2394 | 0.070 |
Why?
|
Rural Population | 2 | 2010 | 2268 | 0.070 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 1 | 2009 | 415 | 0.070 |
Why?
|
Cross-Linking Reagents | 1 | 2010 | 685 | 0.070 |
Why?
|
Activities of Daily Living | 3 | 2012 | 2417 | 0.070 |
Why?
|
Prosencephalon | 1 | 2009 | 305 | 0.070 |
Why?
|
Embryo, Mammalian | 2 | 2011 | 1674 | 0.070 |
Why?
|
Reference Values | 5 | 2008 | 4925 | 0.070 |
Why?
|
Thoracic Wall | 1 | 2009 | 199 | 0.070 |
Why?
|
Cardiovascular Diseases | 1 | 2013 | 15757 | 0.070 |
Why?
|
Vinculin | 1 | 2006 | 59 | 0.070 |
Why?
|
Mice, Inbred C57BL | 8 | 2012 | 22023 | 0.070 |
Why?
|
Creatinine | 1 | 2012 | 1903 | 0.070 |
Why?
|
Sensory Receptor Cells | 1 | 2011 | 509 | 0.070 |
Why?
|
Cattle | 1 | 2012 | 3847 | 0.070 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2012 | 828 | 0.070 |
Why?
|
Mass Spectrometry | 2 | 2013 | 2192 | 0.070 |
Why?
|
Apoptosis | 4 | 2011 | 9501 | 0.070 |
Why?
|
Logistic Models | 5 | 2013 | 13314 | 0.070 |
Why?
|
Hospitals, Public | 1 | 1988 | 201 | 0.070 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2008 | 508 | 0.070 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2010 | 368 | 0.070 |
Why?
|
Poisson Distribution | 1 | 2007 | 507 | 0.070 |
Why?
|
Memory, Short-Term | 2 | 2003 | 978 | 0.070 |
Why?
|
Population Surveillance | 3 | 2014 | 2608 | 0.070 |
Why?
|
Extracellular Matrix Proteins | 1 | 2010 | 829 | 0.070 |
Why?
|
Feces | 1 | 2012 | 1455 | 0.070 |
Why?
|
Bacteria | 2 | 2011 | 2199 | 0.060 |
Why?
|
Psychiatry | 3 | 1998 | 1689 | 0.060 |
Why?
|
Menarche | 1 | 2009 | 529 | 0.060 |
Why?
|
Developing Countries | 2 | 2010 | 2868 | 0.060 |
Why?
|
Connexin 43 | 1 | 2006 | 200 | 0.060 |
Why?
|
Insanity Defense | 1 | 1985 | 28 | 0.060 |
Why?
|
Patient Readmission | 1 | 2000 | 3323 | 0.060 |
Why?
|
Organic Chemicals | 1 | 2006 | 211 | 0.060 |
Why?
|
Zambia | 1 | 2006 | 257 | 0.060 |
Why?
|
Disease | 1 | 2011 | 671 | 0.060 |
Why?
|
American Medical Association | 1 | 1985 | 60 | 0.060 |
Why?
|
Pyridinium Compounds | 2 | 1996 | 81 | 0.060 |
Why?
|
Trail Making Test | 1 | 2005 | 57 | 0.060 |
Why?
|
Epigenomics | 1 | 2011 | 936 | 0.060 |
Why?
|
Immunity, Cellular | 1 | 2011 | 1557 | 0.060 |
Why?
|
Genetic Linkage | 1 | 2010 | 2381 | 0.060 |
Why?
|
New Zealand | 3 | 2013 | 355 | 0.060 |
Why?
|
Glial Cell Line-Derived Neurotrophic Factor | 2 | 2003 | 66 | 0.060 |
Why?
|
Twins, Monozygotic | 1 | 2007 | 469 | 0.060 |
Why?
|
Somatomedins | 1 | 2005 | 178 | 0.060 |
Why?
|
Serine Endopeptidases | 1 | 2010 | 1021 | 0.060 |
Why?
|
Anti-Dyskinesia Agents | 1 | 2004 | 24 | 0.060 |
Why?
|
Waist Circumference | 3 | 2013 | 926 | 0.060 |
Why?
|
Reflex, Acoustic | 1 | 2004 | 34 | 0.060 |
Why?
|
Body Weights and Measures | 1 | 2005 | 208 | 0.060 |
Why?
|
Pilot Projects | 4 | 2006 | 8555 | 0.060 |
Why?
|
Dermis | 1 | 2006 | 202 | 0.060 |
Why?
|
Genetic Heterogeneity | 1 | 2008 | 724 | 0.060 |
Why?
|
Depressive Disorder | 3 | 2008 | 3726 | 0.060 |
Why?
|
Sex Ratio | 1 | 2005 | 107 | 0.060 |
Why?
|
Neuroprotective Agents | 1 | 2011 | 961 | 0.060 |
Why?
|
Mental Recall | 1 | 2010 | 1206 | 0.060 |
Why?
|
Habituation, Psychophysiologic | 1 | 2005 | 147 | 0.060 |
Why?
|
Body Constitution | 1 | 2004 | 273 | 0.060 |
Why?
|
High-Throughput Screening Assays | 1 | 2010 | 944 | 0.060 |
Why?
|
Forensic Psychiatry | 1 | 1985 | 195 | 0.060 |
Why?
|
Cell Proliferation | 4 | 2011 | 10446 | 0.060 |
Why?
|
Secondary Prevention | 1 | 2010 | 1548 | 0.060 |
Why?
|
Intelligence | 1 | 2009 | 921 | 0.060 |
Why?
|
Cell Differentiation | 5 | 2011 | 11481 | 0.060 |
Why?
|
Lymphocytes | 2 | 2010 | 2611 | 0.060 |
Why?
|
Visual Perception | 2 | 2003 | 1374 | 0.060 |
Why?
|
Fetus | 1 | 2011 | 1859 | 0.060 |
Why?
|
Ethics, Medical | 1 | 1989 | 783 | 0.060 |
Why?
|
Brain Neoplasms | 1 | 2005 | 8986 | 0.060 |
Why?
|
Respiratory Tract Infections | 1 | 2011 | 1007 | 0.060 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2010 | 1652 | 0.050 |
Why?
|
Qualitative Research | 1 | 2014 | 2963 | 0.050 |
Why?
|
Aggression | 1 | 2008 | 745 | 0.050 |
Why?
|
Triazoles | 1 | 2009 | 904 | 0.050 |
Why?
|
Suicide, Attempted | 1 | 2012 | 1378 | 0.050 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 1 | 2004 | 159 | 0.050 |
Why?
|
Polymerase Chain Reaction | 4 | 2008 | 6068 | 0.050 |
Why?
|
Time | 1 | 2005 | 545 | 0.050 |
Why?
|
Antioxidants | 1 | 2011 | 1667 | 0.050 |
Why?
|
Medicine in Literature | 1 | 2003 | 31 | 0.050 |
Why?
|
Interdisciplinary Communication | 1 | 2009 | 934 | 0.050 |
Why?
|
Patient Participation | 1 | 2012 | 1439 | 0.050 |
Why?
|
Pirenzepine | 1 | 2003 | 116 | 0.050 |
Why?
|
Wnt Proteins | 1 | 2007 | 719 | 0.050 |
Why?
|
Retrospective Studies | 9 | 2013 | 80372 | 0.050 |
Why?
|
Nutrition Policy | 1 | 2007 | 470 | 0.050 |
Why?
|
Olfactory Pathways | 1 | 2004 | 132 | 0.050 |
Why?
|
Placental Insufficiency | 1 | 2003 | 50 | 0.050 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2004 | 881 | 0.050 |
Why?
|
Treatment Outcome | 9 | 2009 | 65017 | 0.050 |
Why?
|
Tensile Strength | 1 | 2003 | 330 | 0.050 |
Why?
|
Rural Health | 1 | 2004 | 296 | 0.050 |
Why?
|
Remission Induction | 1 | 2008 | 2392 | 0.050 |
Why?
|
Sensory Thresholds | 1 | 2004 | 377 | 0.050 |
Why?
|
Body Size | 1 | 2005 | 462 | 0.050 |
Why?
|
Depression | 2 | 2013 | 8044 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6544 | 0.050 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2006 | 700 | 0.050 |
Why?
|
Recovery of Function | 1 | 2012 | 2985 | 0.050 |
Why?
|
Rats, Inbred F344 | 2 | 2002 | 825 | 0.050 |
Why?
|
Protein Array Analysis | 1 | 2004 | 401 | 0.050 |
Why?
|
3,4-Dihydroxyphenylacetic Acid | 2 | 2013 | 63 | 0.050 |
Why?
|
Apomorphine | 1 | 2002 | 149 | 0.050 |
Why?
|
Medial Forebrain Bundle | 1 | 2002 | 43 | 0.050 |
Why?
|
Proteins | 2 | 2007 | 6029 | 0.050 |
Why?
|
Alleles | 4 | 2008 | 6898 | 0.050 |
Why?
|
Oxidopamine | 1 | 2002 | 172 | 0.050 |
Why?
|
Cooperative Behavior | 1 | 2009 | 1500 | 0.050 |
Why?
|
Smell | 1 | 2004 | 259 | 0.050 |
Why?
|
Patient Dropouts | 1 | 2004 | 412 | 0.050 |
Why?
|
Survival Analysis | 2 | 2013 | 10182 | 0.050 |
Why?
|
Research Design | 2 | 2008 | 6180 | 0.050 |
Why?
|
Urban Health | 1 | 2004 | 533 | 0.050 |
Why?
|
Elasticity | 1 | 2003 | 652 | 0.050 |
Why?
|
Paraplegia | 1 | 2002 | 162 | 0.050 |
Why?
|
Linkage Disequilibrium | 1 | 2006 | 1996 | 0.050 |
Why?
|
Circadian Rhythm | 1 | 2013 | 2571 | 0.050 |
Why?
|
Gene Expression Regulation | 3 | 2012 | 11903 | 0.050 |
Why?
|
Brain Diseases | 1 | 2010 | 1540 | 0.050 |
Why?
|
Dementia | 1 | 1995 | 2649 | 0.050 |
Why?
|
Neurites | 1 | 2003 | 390 | 0.050 |
Why?
|
Skin | 2 | 2012 | 4466 | 0.050 |
Why?
|
Weight-Bearing | 1 | 2003 | 518 | 0.050 |
Why?
|
Public Policy | 1 | 2005 | 560 | 0.050 |
Why?
|
Obesity | 2 | 2013 | 12922 | 0.050 |
Why?
|
Evoked Potentials, Auditory | 1 | 2004 | 529 | 0.050 |
Why?
|
Risperidone | 1 | 2003 | 379 | 0.050 |
Why?
|
Pregnancy Trimester, Third | 1 | 2003 | 582 | 0.050 |
Why?
|
Haplotypes | 2 | 2006 | 2764 | 0.050 |
Why?
|
Monoamine Oxidase | 2 | 2012 | 178 | 0.050 |
Why?
|
Homozygote | 2 | 2012 | 1788 | 0.050 |
Why?
|
Social Behavior | 3 | 2013 | 1131 | 0.050 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2002 | 370 | 0.050 |
Why?
|
Vitamin A | 1 | 2004 | 613 | 0.050 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2012 | 2125 | 0.040 |
Why?
|
Psychomotor Disorders | 1 | 2001 | 149 | 0.040 |
Why?
|
Semantics | 1 | 2004 | 599 | 0.040 |
Why?
|
Nimodipine | 1 | 2000 | 56 | 0.040 |
Why?
|
Schizophrenic Language | 1 | 2000 | 57 | 0.040 |
Why?
|
Nutrition Surveys | 1 | 2007 | 1725 | 0.040 |
Why?
|
Health Promotion | 1 | 2012 | 2206 | 0.040 |
Why?
|
Multiple Sclerosis | 2 | 2012 | 3204 | 0.040 |
Why?
|
Child Custody | 1 | 1999 | 20 | 0.040 |
Why?
|
Geologic Sediments | 1 | 2000 | 79 | 0.040 |
Why?
|
Fingers | 1 | 2003 | 506 | 0.040 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2005 | 707 | 0.040 |
Why?
|
Hormones | 1 | 2004 | 867 | 0.040 |
Why?
|
Extremities | 1 | 2005 | 867 | 0.040 |
Why?
|
Cell Division | 3 | 2006 | 4463 | 0.040 |
Why?
|
Thalamus | 1 | 2006 | 1041 | 0.040 |
Why?
|
Diet | 4 | 2012 | 8010 | 0.040 |
Why?
|
Feasibility Studies | 1 | 2010 | 5201 | 0.040 |
Why?
|
Child Development | 1 | 2011 | 2285 | 0.040 |
Why?
|
Immunoglobulin G | 1 | 2011 | 4541 | 0.040 |
Why?
|
Protein Biosynthesis | 1 | 2007 | 2105 | 0.040 |
Why?
|
Proportional Hazards Models | 2 | 2013 | 12531 | 0.040 |
Why?
|
Genes, Lethal | 1 | 1980 | 225 | 0.040 |
Why?
|
Diltiazem | 1 | 2000 | 131 | 0.040 |
Why?
|
Nifedipine | 1 | 2000 | 221 | 0.040 |
Why?
|
Gait | 1 | 2005 | 812 | 0.040 |
Why?
|
Drug Prescriptions | 1 | 1989 | 1673 | 0.040 |
Why?
|
Verapamil | 1 | 2000 | 242 | 0.040 |
Why?
|
Femur | 1 | 2005 | 1302 | 0.040 |
Why?
|
Catechol O-Methyltransferase | 2 | 2012 | 251 | 0.040 |
Why?
|
Needs Assessment | 1 | 2005 | 1139 | 0.040 |
Why?
|
History, 21st Century | 1 | 2005 | 1575 | 0.040 |
Why?
|
Perceptual Disorders | 1 | 2001 | 197 | 0.040 |
Why?
|
Cell Death | 2 | 2006 | 1672 | 0.040 |
Why?
|
Nicotine | 1 | 2004 | 677 | 0.040 |
Why?
|
Chronic Disease | 4 | 2010 | 9287 | 0.040 |
Why?
|
Family Practice | 1 | 2001 | 510 | 0.040 |
Why?
|
Heat-Shock Proteins | 2 | 2007 | 795 | 0.040 |
Why?
|
Acute Disease | 2 | 2001 | 7269 | 0.040 |
Why?
|
Mechanotransduction, Cellular | 1 | 2003 | 530 | 0.040 |
Why?
|
Mental Processes | 1 | 2000 | 245 | 0.040 |
Why?
|
Stress, Mechanical | 1 | 2003 | 1666 | 0.040 |
Why?
|
Porphyrias | 1 | 1998 | 58 | 0.040 |
Why?
|
Anxiety | 1 | 2013 | 4538 | 0.040 |
Why?
|
Mitosis | 1 | 2003 | 1191 | 0.040 |
Why?
|
Antigens, CD | 1 | 2008 | 4000 | 0.040 |
Why?
|
Prenatal Care | 1 | 2005 | 1129 | 0.040 |
Why?
|
Calcium-Binding Proteins | 1 | 2002 | 1067 | 0.040 |
Why?
|
Interneurons | 1 | 2002 | 591 | 0.040 |
Why?
|
Hand | 1 | 2003 | 903 | 0.040 |
Why?
|
Osteoporosis | 2 | 2012 | 1600 | 0.040 |
Why?
|
Evoked Potentials | 1 | 2003 | 1036 | 0.040 |
Why?
|
Luminescent Proteins | 1 | 2000 | 835 | 0.040 |
Why?
|
Netherlands | 1 | 2002 | 2213 | 0.040 |
Why?
|
Health Behavior | 1 | 2009 | 2622 | 0.040 |
Why?
|
Choice Behavior | 2 | 2013 | 821 | 0.040 |
Why?
|
Sleep | 1 | 2013 | 4751 | 0.030 |
Why?
|
Computer Simulation | 3 | 2005 | 6218 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2003 | 2061 | 0.030 |
Why?
|
Laughter | 1 | 1996 | 19 | 0.030 |
Why?
|
Hippocampus | 3 | 2006 | 3738 | 0.030 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 1998 | 174 | 0.030 |
Why?
|
Adaptation, Physiological | 1 | 2003 | 1296 | 0.030 |
Why?
|
Cells, Cultured | 5 | 2006 | 18957 | 0.030 |
Why?
|
Collagen | 1 | 2005 | 2636 | 0.030 |
Why?
|
Crying | 1 | 1996 | 37 | 0.030 |
Why?
|
Suicide | 1 | 2007 | 1599 | 0.030 |
Why?
|
Nerve Regeneration | 1 | 2002 | 791 | 0.030 |
Why?
|
Functional Laterality | 1 | 2003 | 2253 | 0.030 |
Why?
|
Knee Joint | 1 | 2005 | 1663 | 0.030 |
Why?
|
National Health Programs | 2 | 2014 | 441 | 0.030 |
Why?
|
Gyrus Cinguli | 1 | 2002 | 1114 | 0.030 |
Why?
|
Heart | 1 | 1989 | 4393 | 0.030 |
Why?
|
Oxidoreductases | 1 | 1998 | 412 | 0.030 |
Why?
|
Immunohistochemistry | 5 | 2013 | 11071 | 0.030 |
Why?
|
Gene Frequency | 3 | 2010 | 3615 | 0.030 |
Why?
|
Drug Administration Schedule | 2 | 2003 | 4899 | 0.030 |
Why?
|
Species Specificity | 2 | 2012 | 2418 | 0.030 |
Why?
|
Brain Damage, Chronic | 1 | 1996 | 267 | 0.030 |
Why?
|
Famotidine | 1 | 1995 | 17 | 0.030 |
Why?
|
Dopamine Antagonists | 1 | 1996 | 288 | 0.030 |
Why?
|
Remoxipride | 1 | 1994 | 2 | 0.030 |
Why?
|
Immunophenotyping | 2 | 2010 | 1871 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2005 | 2828 | 0.030 |
Why?
|
Thioridazine | 1 | 1994 | 33 | 0.030 |
Why?
|
Interprofessional Relations | 1 | 2001 | 989 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2004 | 2907 | 0.030 |
Why?
|
Leukopenia | 1 | 1995 | 211 | 0.030 |
Why?
|
Survival Rate | 1 | 2009 | 12808 | 0.030 |
Why?
|
Zidovudine | 1 | 1996 | 624 | 0.030 |
Why?
|
Calcitriol | 2 | 2007 | 297 | 0.030 |
Why?
|
Bromodeoxyuridine | 2 | 2005 | 311 | 0.030 |
Why?
|
Interleukin-3 | 1 | 1995 | 425 | 0.030 |
Why?
|
Biopsy | 3 | 2006 | 6771 | 0.030 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 1996 | 590 | 0.030 |
Why?
|
Prognosis | 2 | 2012 | 29658 | 0.030 |
Why?
|
Hospitalization | 4 | 2012 | 10790 | 0.030 |
Why?
|
Helplessness, Learned | 1 | 2013 | 28 | 0.030 |
Why?
|
Pedigree | 2 | 2012 | 4578 | 0.030 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 1996 | 629 | 0.030 |
Why?
|
Cerebral Cortex | 1 | 2010 | 5761 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2004 | 6498 | 0.030 |
Why?
|
Carcinoma, Lobular | 1 | 1998 | 489 | 0.030 |
Why?
|
Mitochondria | 1 | 2006 | 3600 | 0.030 |
Why?
|
Social Isolation | 2 | 2010 | 362 | 0.030 |
Why?
|
Societies, Medical | 1 | 1985 | 3905 | 0.030 |
Why?
|
Cell Adhesion | 1 | 1999 | 3094 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2006 | 4938 | 0.030 |
Why?
|
Algorithms | 1 | 2013 | 13981 | 0.030 |
Why?
|
Nervous System | 1 | 1996 | 543 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2005 | 14372 | 0.030 |
Why?
|
Double-Blind Method | 4 | 2003 | 12427 | 0.030 |
Why?
|
Birth Order | 1 | 2013 | 95 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2004 | 12159 | 0.030 |
Why?
|
Primary Prevention | 1 | 2000 | 1207 | 0.030 |
Why?
|
Glutamate-Ammonia Ligase | 1 | 2012 | 72 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2010 | 20080 | 0.030 |
Why?
|
HMGB Proteins | 1 | 2012 | 45 | 0.030 |
Why?
|
Indonesia | 1 | 2012 | 127 | 0.030 |
Why?
|
India | 2 | 2012 | 2336 | 0.030 |
Why?
|
G2 Phase | 1 | 1993 | 133 | 0.030 |
Why?
|
Carboxyhemoglobin | 2 | 1989 | 80 | 0.030 |
Why?
|
Health Planning | 1 | 2014 | 232 | 0.030 |
Why?
|
Biological Transport | 1 | 1997 | 2086 | 0.030 |
Why?
|
gamma-Aminobutyric Acid | 2 | 2013 | 1132 | 0.030 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2013 | 186 | 0.030 |
Why?
|
Empirical Research | 1 | 2012 | 120 | 0.030 |
Why?
|
Bone Density | 1 | 2005 | 3534 | 0.030 |
Why?
|
Spermatogenesis | 1 | 2013 | 257 | 0.030 |
Why?
|
Cyclin A2 | 1 | 2011 | 21 | 0.030 |
Why?
|
Sibling Relations | 1 | 1992 | 46 | 0.030 |
Why?
|
Burns | 1 | 2003 | 1866 | 0.020 |
Why?
|
Malaysia | 1 | 2012 | 107 | 0.020 |
Why?
|
Disease Progression | 1 | 2009 | 13502 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2003 | 4357 | 0.020 |
Why?
|
Glutamate Decarboxylase | 1 | 2012 | 239 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2008 | 15289 | 0.020 |
Why?
|
Catecholamines | 1 | 2012 | 385 | 0.020 |
Why?
|
Sunbathing | 1 | 2012 | 65 | 0.020 |
Why?
|
Neuroanatomy | 1 | 2012 | 70 | 0.020 |
Why?
|
Inflammation | 1 | 2011 | 10756 | 0.020 |
Why?
|
Body Fat Distribution | 1 | 2013 | 243 | 0.020 |
Why?
|
Eye Diseases | 1 | 1997 | 651 | 0.020 |
Why?
|
Cyclin E | 1 | 2011 | 155 | 0.020 |
Why?
|
Occupations | 1 | 1993 | 515 | 0.020 |
Why?
|
Birth Injuries | 1 | 2012 | 150 | 0.020 |
Why?
|
Body Mass Index | 3 | 2013 | 12914 | 0.020 |
Why?
|
Hydroxycholecalciferols | 1 | 2010 | 44 | 0.020 |
Why?
|
Nutritional Requirements | 1 | 2012 | 275 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2009 | 9276 | 0.020 |
Why?
|
Bangladesh | 1 | 2012 | 728 | 0.020 |
Why?
|
Hemodynamics | 1 | 2001 | 4174 | 0.020 |
Why?
|
Toxoplasma | 1 | 2011 | 151 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2005 | 4925 | 0.020 |
Why?
|
Health Status Disparities | 2 | 2012 | 1830 | 0.020 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 1998 | 1096 | 0.020 |
Why?
|
Fathers | 1 | 2013 | 376 | 0.020 |
Why?
|
Herpesvirus 2, Human | 1 | 2011 | 191 | 0.020 |
Why?
|
Accidents, Traffic | 1 | 1996 | 814 | 0.020 |
Why?
|
Genetic Markers | 1 | 1996 | 2608 | 0.020 |
Why?
|
Homovanillic Acid | 1 | 2009 | 75 | 0.020 |
Why?
|
Peru | 1 | 2012 | 869 | 0.020 |
Why?
|
Cyclin D1 | 1 | 2011 | 451 | 0.020 |
Why?
|
Hydroxyindoleacetic Acid | 1 | 2009 | 93 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2012 | 1763 | 0.020 |
Why?
|
Cell Shape | 1 | 2010 | 372 | 0.020 |
Why?
|
Mastectomy, Modified Radical | 1 | 2009 | 62 | 0.020 |
Why?
|
Clozapine | 1 | 2012 | 506 | 0.020 |
Why?
|
Adjustment Disorders | 1 | 1989 | 67 | 0.020 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2010 | 452 | 0.020 |
Why?
|
Lymphatic Irradiation | 1 | 2009 | 115 | 0.020 |
Why?
|
Osmosis | 1 | 1988 | 103 | 0.020 |
Why?
|
Altitude Sickness | 1 | 1989 | 91 | 0.020 |
Why?
|
Walking | 1 | 1996 | 1189 | 0.020 |
Why?
|
Blood Glucose | 2 | 2013 | 6381 | 0.020 |
Why?
|
HIV-1 | 2 | 1996 | 6849 | 0.020 |
Why?
|
Caudate Nucleus | 1 | 2009 | 389 | 0.020 |
Why?
|
Exons | 2 | 2008 | 2388 | 0.020 |
Why?
|
Tanzania | 1 | 2012 | 1383 | 0.020 |
Why?
|
Manuals as Topic | 1 | 1988 | 99 | 0.020 |
Why?
|
Rats, Inbred Strains | 1 | 1989 | 2094 | 0.020 |
Why?
|
Tasmania | 1 | 2007 | 4 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2011 | 987 | 0.020 |
Why?
|
Hematocrit | 1 | 1989 | 629 | 0.020 |
Why?
|
Arousal | 1 | 1993 | 1157 | 0.020 |
Why?
|
Observation | 1 | 2009 | 312 | 0.020 |
Why?
|
Freezing | 1 | 1988 | 306 | 0.020 |
Why?
|
Maryland | 1 | 1988 | 275 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 2 | 2010 | 1827 | 0.020 |
Why?
|
Canada | 1 | 2013 | 2128 | 0.020 |
Why?
|
Down-Regulation | 2 | 2006 | 2913 | 0.020 |
Why?
|
Probability | 1 | 2012 | 2475 | 0.020 |
Why?
|
Unemployment | 1 | 1989 | 209 | 0.020 |
Why?
|
Workplace | 1 | 1993 | 857 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2013 | 1817 | 0.020 |
Why?
|
Twin Studies as Topic | 1 | 2007 | 104 | 0.020 |
Why?
|
Cytomegalovirus | 1 | 2011 | 755 | 0.020 |
Why?
|
Breast Neoplasms | 2 | 2009 | 21025 | 0.020 |
Why?
|
United States | 3 | 2012 | 72461 | 0.020 |
Why?
|
Thermodynamics | 1 | 1988 | 599 | 0.020 |
Why?
|
Cardiac Output | 1 | 1989 | 838 | 0.020 |
Why?
|
Genetics, Population | 1 | 2011 | 930 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 2008 | 1304 | 0.020 |
Why?
|
Dystrophin-Associated Proteins | 1 | 2006 | 59 | 0.020 |
Why?
|
Norepinephrine | 1 | 2009 | 900 | 0.020 |
Why?
|
Cell Membrane Permeability | 1 | 1988 | 575 | 0.020 |
Why?
|
Synaptic Transmission | 1 | 2012 | 1171 | 0.020 |
Why?
|
Reproduction | 1 | 2011 | 646 | 0.020 |
Why?
|
3' Untranslated Regions | 1 | 2008 | 514 | 0.020 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2011 | 893 | 0.020 |
Why?
|
Gender Identity | 1 | 1992 | 698 | 0.020 |
Why?
|
Eating | 1 | 2013 | 1539 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2013 | 2435 | 0.020 |
Why?
|
Herpesvirus 1, Human | 1 | 2011 | 753 | 0.020 |
Why?
|
Mutation | 3 | 2013 | 29932 | 0.020 |
Why?
|
China | 1 | 2012 | 2339 | 0.020 |
Why?
|
Cycloheximide | 1 | 2006 | 343 | 0.020 |
Why?
|
Metabolic Networks and Pathways | 1 | 2010 | 789 | 0.020 |
Why?
|
Triglycerides | 1 | 2013 | 2476 | 0.020 |
Why?
|
Mitotic Index | 1 | 2006 | 161 | 0.020 |
Why?
|
HIV Core Protein p24 | 2 | 1996 | 245 | 0.020 |
Why?
|
Organogenesis | 1 | 2007 | 215 | 0.020 |
Why?
|
Communication | 1 | 2000 | 3849 | 0.020 |
Why?
|
Corticosterone | 1 | 2006 | 304 | 0.020 |
Why?
|
Thermal Conductivity | 1 | 2005 | 16 | 0.020 |
Why?
|
Rotarod Performance Test | 1 | 2005 | 63 | 0.020 |
Why?
|
Blotting, Western | 1 | 2013 | 5039 | 0.020 |
Why?
|
Genetics, Behavioral | 1 | 2005 | 53 | 0.020 |
Why?
|
Diseases in Twins | 1 | 2007 | 447 | 0.020 |
Why?
|
Blood Pressure | 2 | 2012 | 8525 | 0.020 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2005 | 119 | 0.020 |
Why?
|
Blood Cell Count | 2 | 1996 | 397 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2852 | 0.020 |
Why?
|
Th1 Cells | 1 | 2010 | 1032 | 0.020 |
Why?
|
Phosphatidylinositols | 1 | 2006 | 282 | 0.020 |
Why?
|
Organ Size | 1 | 2010 | 2254 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 2008 | 5785 | 0.020 |
Why?
|
Receptors, Glucocorticoid | 1 | 2006 | 296 | 0.010 |
Why?
|
Cricetinae | 1 | 1988 | 2427 | 0.010 |
Why?
|
Maternal-Fetal Exchange | 1 | 2007 | 463 | 0.010 |
Why?
|
Immune System | 1 | 2010 | 798 | 0.010 |
Why?
|
Psychomotor Performance | 2 | 2003 | 1878 | 0.010 |
Why?
|
Serotonin | 1 | 2009 | 1040 | 0.010 |
Why?
|
Lactoglobulins | 1 | 1983 | 22 | 0.010 |
Why?
|
Neoplasm Staging | 3 | 2009 | 11152 | 0.010 |
Why?
|
Diffusion | 1 | 2006 | 813 | 0.010 |
Why?
|
Lateral Ventricles | 1 | 2005 | 146 | 0.010 |
Why?
|
Immunoglobulin A, Secretory | 1 | 1983 | 104 | 0.010 |
Why?
|
Fiji | 1 | 2003 | 47 | 0.010 |
Why?
|
Antiviral Agents | 1 | 1996 | 3061 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2005 | 1543 | 0.010 |
Why?
|
Caspase 3 | 1 | 2006 | 731 | 0.010 |
Why?
|
Disabled Persons | 1 | 2013 | 1223 | 0.010 |
Why?
|
Roman World | 1 | 2003 | 2 | 0.010 |
Why?
|
Heart Conduction System | 1 | 1989 | 1015 | 0.010 |
Why?
|
Greek World | 1 | 2003 | 6 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2012 | 6216 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2009 | 1791 | 0.010 |
Why?
|
Leprosy | 1 | 1983 | 125 | 0.010 |
Why?
|
Fear | 1 | 2012 | 1462 | 0.010 |
Why?
|
Lactoferrin | 1 | 1983 | 100 | 0.010 |
Why?
|
Organ Culture Techniques | 1 | 2005 | 796 | 0.010 |
Why?
|
Phosphates | 1 | 2007 | 772 | 0.010 |
Why?
|
Receptor, Nerve Growth Factor | 1 | 2003 | 48 | 0.010 |
Why?
|
Coronary Circulation | 1 | 1989 | 1577 | 0.010 |
Why?
|
Treatment Failure | 2 | 2000 | 2648 | 0.010 |
Why?
|
Genetic Engineering | 1 | 1989 | 933 | 0.010 |
Why?
|
Cell Survival | 2 | 2005 | 5797 | 0.010 |
Why?
|
Tumor Burden | 1 | 2009 | 1895 | 0.010 |
Why?
|
Systems Biology | 1 | 2006 | 482 | 0.010 |
Why?
|
Caspases | 1 | 2006 | 878 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 1989 | 1843 | 0.010 |
Why?
|
History, Ancient | 1 | 2003 | 211 | 0.010 |
Why?
|
Connective Tissue | 1 | 2005 | 416 | 0.010 |
Why?
|
Therapy, Computer-Assisted | 1 | 2005 | 267 | 0.010 |
Why?
|
Culture Techniques | 1 | 2003 | 530 | 0.010 |
Why?
|
Radiotherapy Dosage | 2 | 2000 | 2897 | 0.010 |
Why?
|
Molecular Chaperones | 1 | 2007 | 752 | 0.010 |
Why?
|
Quantitative Trait Loci | 1 | 2010 | 2101 | 0.010 |
Why?
|
Recurrence | 2 | 1998 | 8482 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2000 | 5251 | 0.010 |
Why?
|
Water | 1 | 1988 | 1407 | 0.010 |
Why?
|
Tubulin | 1 | 2005 | 692 | 0.010 |
Why?
|
Alcohol Deterrents | 1 | 2002 | 49 | 0.010 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2003 | 198 | 0.010 |
Why?
|
Drug Interactions | 1 | 2006 | 1428 | 0.010 |
Why?
|
Models, Statistical | 1 | 1996 | 5075 | 0.010 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2002 | 303 | 0.010 |
Why?
|
Lipids | 1 | 2012 | 3336 | 0.010 |
Why?
|
Antifungal Agents | 1 | 2006 | 749 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2009 | 2943 | 0.010 |
Why?
|
Albumins | 1 | 1983 | 575 | 0.010 |
Why?
|
Cell Movement | 1 | 2013 | 5206 | 0.010 |
Why?
|
Photobiology | 1 | 2000 | 10 | 0.010 |
Why?
|
Siberia | 1 | 2000 | 30 | 0.010 |
Why?
|
Receptors, GABA-A | 1 | 2005 | 621 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2013 | 3185 | 0.010 |
Why?
|
Mastectomy | 1 | 2009 | 1832 | 0.010 |
Why?
|
Liver | 1 | 1996 | 7509 | 0.010 |
Why?
|
Internet | 1 | 2012 | 3078 | 0.010 |
Why?
|
Light | 1 | 2006 | 1344 | 0.010 |
Why?
|
Parathyroid Hormone | 1 | 2007 | 1797 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2005 | 12766 | 0.010 |
Why?
|
Radiotherapy, High-Energy | 1 | 2000 | 228 | 0.010 |
Why?
|
Breast | 1 | 2009 | 1963 | 0.010 |
Why?
|
Atrophy | 1 | 2005 | 1627 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2012 | 9530 | 0.010 |
Why?
|
Verbal Learning | 1 | 2002 | 462 | 0.010 |
Why?
|
Microtubule-Associated Proteins | 1 | 2005 | 1077 | 0.010 |
Why?
|
Ice | 1 | 2000 | 102 | 0.010 |
Why?
|
HIV Infections | 2 | 1996 | 17165 | 0.010 |
Why?
|
Milk, Human | 1 | 1983 | 483 | 0.010 |
Why?
|
Genitalia, Female | 1 | 1980 | 147 | 0.010 |
Why?
|
Receptors, Dopamine | 1 | 1999 | 292 | 0.010 |
Why?
|
Protoporphyrinogen Oxidase | 1 | 1998 | 3 | 0.010 |
Why?
|
Sperm Motility | 1 | 1980 | 265 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2009 | 6828 | 0.010 |
Why?
|
Nucleic Acid Heteroduplexes | 1 | 1998 | 46 | 0.010 |
Why?
|
Flavoproteins | 1 | 1998 | 40 | 0.010 |
Why?
|
Body Weight | 2 | 2005 | 4611 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4573 | 0.010 |
Why?
|
Recombinant Proteins | 2 | 2000 | 6538 | 0.010 |
Why?
|
Public Opinion | 1 | 1982 | 481 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 3 | 2012 | 36290 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 2010 | 2250 | 0.010 |
Why?
|
Heart Rate | 1 | 1989 | 4179 | 0.010 |
Why?
|
Antibodies | 1 | 2005 | 2421 | 0.010 |
Why?
|
Stereoisomerism | 1 | 1998 | 617 | 0.010 |
Why?
|
Narcotic Antagonists | 1 | 2002 | 583 | 0.010 |
Why?
|
Olfactory Marker Protein | 1 | 1996 | 12 | 0.010 |
Why?
|
Cytological Techniques | 1 | 1998 | 218 | 0.010 |
Why?
|
Electroconvulsive Therapy | 1 | 1982 | 502 | 0.010 |
Why?
|
Cold Temperature | 1 | 2000 | 780 | 0.010 |
Why?
|
Myocardium | 1 | 1989 | 4700 | 0.010 |
Why?
|
Culture Media, Serum-Free | 1 | 1996 | 148 | 0.010 |
Why?
|
Pattern Recognition, Visual | 1 | 2002 | 810 | 0.010 |
Why?
|
Culture Media | 1 | 1998 | 900 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2000 | 13262 | 0.010 |
Why?
|
Ecosystem | 1 | 2000 | 485 | 0.010 |
Why?
|
Electrocardiography | 1 | 1989 | 6414 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2003 | 1535 | 0.010 |
Why?
|
Virus Cultivation | 1 | 1995 | 88 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2006 | 5870 | 0.010 |
Why?
|
Los Angeles | 1 | 1996 | 243 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 1996 | 532 | 0.010 |
Why?
|
Hospitals, State | 1 | 1995 | 29 | 0.010 |
Why?
|
Length of Stay | 1 | 1989 | 6479 | 0.010 |
Why?
|
Cytokines | 1 | 2010 | 7343 | 0.010 |
Why?
|
Drug Costs | 1 | 2003 | 1185 | 0.010 |
Why?
|
Hospitals, Private | 1 | 1995 | 63 | 0.010 |
Why?
|
Language | 1 | 2004 | 1533 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2000 | 2057 | 0.010 |
Why?
|
Genome, Human | 1 | 2007 | 4417 | 0.010 |
Why?
|
Pneumonectomy | 1 | 2000 | 1111 | 0.010 |
Why?
|
Epithelium | 1 | 1998 | 1605 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2005 | 3663 | 0.010 |
Why?
|
Diffusion of Innovation | 1 | 1998 | 730 | 0.010 |
Why?
|
Neoplasm, Residual | 1 | 1998 | 1007 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2006 | 7593 | 0.010 |
Why?
|
Cell Polarity | 1 | 1996 | 638 | 0.010 |
Why?
|
Phylogeny | 1 | 2000 | 2775 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 1999 | 2651 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 1995 | 20509 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2007 | 5791 | 0.010 |
Why?
|
Injury Severity Score | 1 | 1996 | 1033 | 0.010 |
Why?
|
Transfection | 1 | 2000 | 5781 | 0.010 |
Why?
|
Mitochondrial Proteins | 1 | 1998 | 979 | 0.010 |
Why?
|
Cell Count | 1 | 1996 | 1835 | 0.010 |
Why?
|
Oxidation-Reduction | 1 | 1998 | 2222 | 0.010 |
Why?
|
Fertilization in Vitro | 1 | 1980 | 1292 | 0.010 |
Why?
|
Gene Expression | 1 | 2004 | 7588 | 0.010 |
Why?
|
Neurologic Examination | 1 | 1994 | 916 | 0.010 |
Why?
|
Trauma Centers | 1 | 1996 | 933 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2003 | 5508 | 0.010 |
Why?
|
Stem Cells | 1 | 2003 | 3523 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2007 | 9585 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2000 | 8552 | 0.000 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2000 | 11712 | 0.000 |
Why?
|
Transcription Factors | 1 | 2007 | 12103 | 0.000 |
Why?
|
Base Sequence | 1 | 1998 | 12446 | 0.000 |
Why?
|
RNA, Viral | 1 | 1995 | 2838 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1998 | 13451 | 0.000 |
Why?
|
Neural Pathways | 1 | 1996 | 3040 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1998 | 17624 | 0.000 |
Why?
|
Attitude of Health Personnel | 1 | 1998 | 3865 | 0.000 |
Why?
|
Scotland | 1 | 1983 | 143 | 0.000 |
Why?
|
Ethiopia | 1 | 1983 | 462 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1996 | 12965 | 0.000 |
Why?
|
Practice Guidelines as Topic | 1 | 1998 | 7475 | 0.000 |
Why?
|
Epidemiologic Methods | 1 | 1983 | 1343 | 0.000 |
Why?
|
Heart Ventricles | 1 | 1989 | 3811 | 0.000 |
Why?
|
Postpartum Period | 1 | 1983 | 1167 | 0.000 |
Why?
|
Patient Education as Topic | 1 | 1982 | 2315 | 0.000 |
Why?
|
Patient Acceptance of Health Care | 1 | 1982 | 3164 | 0.000 |
Why?
|